Doogan Declan 13D/13G Filings for Tenax Therapeutics, Inc. (TENX)

Doogan Declan 13D and 13G filings for Tenax Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-09
4:31 pm
Unchanged
2023-02-0713DTenax Therapeutics, Inc.
TENX
Doogan Declan2,274
1.960%
0
(Unchanged)
Filing
2023-01-06
4:30 pm
Purchase
2022-11-0713DTenax Therapeutics, Inc.
TENX
Doogan Declan2,274
7.940%
2,274increase
(New Position)
Filing